ImmunityBio, Inc. IBRX Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Other revenues | $39K+200% | $13K-95.4% | $281K+6,925% | $4K-50.0% | $8K-97.7% | |
| Product revenue, net | $44.17M+15.4% | $38.27M+20.4% | $31.78M+20.3% | $26.42M+60.0% | $16.51M+129% | |
| Revenue by Geography | ||||||
| Europe | $24K+50.0% | $16K-93.9% | $262K— | $0— | $0-100% | |
| U.S. | $44.18M+15.5% | $38.27M+20.3% | $31.8M+20.3% | $26.43M+60.0% | $16.52M+129% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ImmunityBio, Inc. break its business down?
- ImmunityBio, Inc. (IBRX) reports total revenue by product across 2 parts — Other revenues and Product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does ImmunityBio, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ImmunityBio, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
